JP2007502608A5 - - Google Patents

Download PDF

Info

Publication number
JP2007502608A5
JP2007502608A5 JP2006523593A JP2006523593A JP2007502608A5 JP 2007502608 A5 JP2007502608 A5 JP 2007502608A5 JP 2006523593 A JP2006523593 A JP 2006523593A JP 2006523593 A JP2006523593 A JP 2006523593A JP 2007502608 A5 JP2007502608 A5 JP 2007502608A5
Authority
JP
Japan
Prior art keywords
cells
cell
mammalian
feeder
free conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006523593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007502608A6 (ja
JP5129959B2 (ja
JP2007502608A (ja
Filing date
Publication date
Priority claimed from DE10338531A external-priority patent/DE10338531A1/de
Application filed filed Critical
Publication of JP2007502608A publication Critical patent/JP2007502608A/ja
Publication of JP2007502608A6 publication Critical patent/JP2007502608A6/ja
Publication of JP2007502608A5 publication Critical patent/JP2007502608A5/ja
Application granted granted Critical
Publication of JP5129959B2 publication Critical patent/JP5129959B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006523593A 2003-08-19 2004-08-17 生産細胞の再クローン化方法 Expired - Fee Related JP5129959B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10338531.2 2003-08-19
DE10338531A DE10338531A1 (de) 2003-08-19 2003-08-19 Verfahren zur Reklonierung von Produktionszellen
PCT/EP2004/009204 WO2005019442A2 (de) 2003-08-19 2004-08-17 Verfahren zur reklonierung von produktionszellen

Publications (4)

Publication Number Publication Date
JP2007502608A JP2007502608A (ja) 2007-02-15
JP2007502608A6 JP2007502608A6 (ja) 2007-05-10
JP2007502608A5 true JP2007502608A5 (enExample) 2007-10-04
JP5129959B2 JP5129959B2 (ja) 2013-01-30

Family

ID=34201814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006523593A Expired - Fee Related JP5129959B2 (ja) 2003-08-19 2004-08-17 生産細胞の再クローン化方法

Country Status (11)

Country Link
US (1) US7833787B2 (enExample)
EP (2) EP1918364B1 (enExample)
JP (1) JP5129959B2 (enExample)
KR (1) KR101184572B1 (enExample)
AT (2) ATE515565T1 (enExample)
CA (1) CA2536239C (enExample)
DE (2) DE10338531A1 (enExample)
DK (2) DK1918364T3 (enExample)
ES (2) ES2317023T3 (enExample)
TW (1) TWI337201B (enExample)
WO (1) WO2005019442A2 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060223183A1 (en) * 2005-03-11 2006-10-05 Bates Steven E Gamma irradiation of frozen feeder cells
EP1901068A1 (en) * 2006-09-15 2008-03-19 Boehringer Ingelheim Pharma GmbH & Co. KG Methods of selecting cell clones
WO2008031873A1 (en) * 2006-09-15 2008-03-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methods of selecting cell clones
EP2257620A1 (de) * 2008-03-19 2010-12-08 Boehringer Ingelheim Pharma GmbH & Co. KG Methode zur steigerung der reklonierungseffizienz
JP5304275B2 (ja) * 2009-01-29 2013-10-02 Jnc株式会社 アポクライティン−iiをコードするコドン最適化核酸およびその使用方法
JP5710588B2 (ja) 2009-04-09 2015-04-30 セルカ ゲーエムベーハー 単一細胞クローニングの改良法
US9493776B2 (en) 2009-11-19 2016-11-15 National University Corporation Okayama University System for increasing gene expression and vector comprising the system
LT2771031T (lt) 2011-10-28 2018-08-27 Prothena Biosciences Limited Humanizuoti antikūnai, kurie atpažįsta alfa sinukleiną
UA115439C2 (uk) 2012-01-27 2017-11-10 Протена Біосаєнсиз Лімітед Гуманізоване антитіло, яке розпізнає альфа-синуклеїн
UA118441C2 (uk) 2012-10-08 2019-01-25 Протена Біосаєнсиз Лімітед Антитіло, що розпізнає альфа-синуклеїн
JP6674888B2 (ja) 2013-03-13 2020-04-01 プロセナ バイオサイエンシーズ リミテッド タウ免疫療法
US10513555B2 (en) 2013-07-04 2019-12-24 Prothena Biosciences Limited Antibody formulations and methods
US9850302B2 (en) 2013-07-12 2017-12-26 Prothena Biosciences Limited Antibodies that recognize IAPP
US9951131B2 (en) 2013-07-12 2018-04-24 Prothena Biosciences Limited Antibodies that recognize IAPP
US11191832B2 (en) 2013-11-19 2021-12-07 Prothena Biosciences Limited Monitoring immunotherapy of Lewy body disease from constipation symptoms
TW201623331A (zh) 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
ES2744526T3 (es) 2014-03-12 2020-02-25 Prothena Biosciences Ltd Anticuerpos anti-MCAM y métodos de uso asociados
CA2938933A1 (en) 2014-03-12 2015-09-17 Prothena Biosciences Limited Anti-laminin4 antibodies specific for lg4-5
KR20160131082A (ko) 2014-03-12 2016-11-15 프로테나 바이오사이언시즈 리미티드 Lg1-3에 특이적인 항-라미닌4 항체
WO2015155694A1 (en) 2014-04-08 2015-10-15 Prothena Biosciences Limited Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
TWI718121B (zh) 2015-01-28 2021-02-11 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
TWI718122B (zh) 2015-01-28 2021-02-11 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
TWI769570B (zh) 2015-01-28 2022-07-01 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
WO2017046776A2 (en) 2015-09-16 2017-03-23 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
WO2017046774A2 (en) 2015-09-16 2017-03-23 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
WO2017149513A1 (en) 2016-03-03 2017-09-08 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
WO2017153953A1 (en) 2016-03-09 2017-09-14 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
WO2017153955A1 (en) 2016-03-09 2017-09-14 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
CN109219615B (zh) 2016-05-02 2022-12-09 普罗塞纳生物科学有限公司 识别tau的抗体
EP3452509A1 (en) 2016-05-02 2019-03-13 Prothena Biosciences Limited Antibodies recognizing tau
PL3452507T3 (pl) 2016-05-02 2023-01-09 Prothena Biosciences Limited Immunoterapia tau
WO2017208210A1 (en) 2016-06-03 2017-12-07 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
EP3478714A2 (en) 2016-07-02 2019-05-08 Prothena Biosciences Limited Anti-transthyretin antibodies
WO2018007923A2 (en) 2016-07-02 2018-01-11 Prothena Biosciences Limited Anti-transthyretin antibodies
EP3478716A2 (en) 2016-07-02 2019-05-08 Prothena Biosciences Limited Anti-transthyretin antibodies
CN110881274B (zh) 2017-05-02 2024-11-15 普罗塞纳生物科学有限公司 识别tau的抗体
JP2021502955A (ja) 2017-09-28 2021-02-04 プロセナ・バイオサイエンシズ・リミテッド シヌクレイン病の治療のための投与レジメン
JP7292569B2 (ja) 2017-10-06 2023-06-19 ノボ ノルディスク エー/エス トランスサイレチンを検出する方法
PE20211453A1 (es) 2017-11-29 2021-08-05 Prothena Biosciences Ltd Formulacion liofilizada de un anticuerpo monoclonal contra transtirretina
WO2020097561A1 (en) 2018-11-08 2020-05-14 Prothena Biosciences Limited Antibodies recognizing tau
CR20210272A (es) 2018-11-26 2021-07-14 Forty Seven Inc Anticuerpos humanizados contra c-kit
AU2020231366A1 (en) 2019-03-03 2021-08-12 Prothena Biosciences Limited Antibodies recognizing tau
CA3183994A1 (en) 2020-06-24 2021-12-30 Philip James Dolan Iii Antibodies recognizing sortilin
TW202530246A (zh) 2023-09-15 2025-08-01 愛爾蘭商歐賽爾普羅希那有限公司 細胞穿透劑及其用途
AR133830A1 (es) 2023-09-15 2025-11-05 Prothena Platform Tech Limited Métodos, composiciones y kits que incluyen agentes de penetración celular
WO2025059486A1 (en) 2023-09-15 2025-03-20 Prothena Biosciences Limited Anti-tdp-43 antibodies and uses thereof
AR133834A1 (es) 2023-09-15 2025-11-05 Prothena Biosciences Ltd Agentes de penetración célular y sus usos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584341D1 (de) 1984-08-24 1991-11-14 Upjohn Co Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
US5008198A (en) 1984-09-14 1991-04-16 Scripps Clinic And Research Foundation Merozoite surface glycoproteins
EP0557459B1 (en) 1990-11-13 1997-10-22 Immunex Corporation Bifunctional selectable fusion genes
US5459058A (en) * 1991-03-28 1995-10-17 Benjamin Rich Cell culture system
WO1994028143A1 (en) 1993-05-21 1994-12-08 Targeted Genetics Corporation Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
DE19539493A1 (de) 1995-10-24 1997-04-30 Thomae Gmbh Dr K Starker homologer Promotor aus Hamster
EP1071747B1 (fr) 1998-04-17 2004-08-18 Societe Des Produits Nestle S.A. Lignee de cellules immortalisees derivees de tissus cutanes humains normaux
WO2001027150A2 (en) 1999-10-14 2001-04-19 Clontech Laboratories Inc. Anthozoa derived chromo/fluoroproteins and methods for using the same
EP1135532B1 (en) 1998-12-11 2011-03-16 Clontech Laboratories Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
WO2000034318A1 (en) 1998-12-11 2000-06-15 Clontech Laboratories, Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
WO2000034326A1 (en) 1998-12-11 2000-06-15 Clontech Laboratories, Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
DK1196566T3 (da) 1999-07-12 2006-06-06 Genentech Inc Ekspressionsvektorer og -metoder
EP1200561B1 (de) * 1999-08-05 2006-06-14 Baxter Aktiengesellschaft Rekombinanter stabiler zellklon, seine herstellung und verwendung
US7456017B2 (en) * 1999-10-01 2008-11-25 University Of North Carolina At Chapel Hill Processes for clonal growth of hepatic progenitor cells
CN1461341A (zh) * 2000-10-03 2003-12-10 北卡罗来纳大学 肝祖先细胞克隆生长的方法
US20030073234A1 (en) * 2001-10-12 2003-04-17 Michal Amit Clonal human embryonic stem cell lines and methods of generating same

Similar Documents

Publication Publication Date Title
JP2007502608A5 (enExample)
JP6177260B2 (ja) 連続細胞培養で対象となるポリペプチドまたはウイルスを生成する方法
JP2010263903A (ja) 哺乳動物細胞中で分泌型組換えタンパク質を高生産させるための分子シャペロンの使用方法
WO2007015848A3 (en) Improved methods and compositions for increasing longevity and protein yield from a cell culture
CN109777773A (zh) 一种从造血干细胞分化产生nk细胞的方法及其培养基
Van der Velden-de Groot Microcarrier technology, present status and perspective
Lee et al. Red blood cell generation by three-dimensional aggregate cultivation of late erythroblasts
CN106414722A (zh) 红系细胞的体外扩增
Prentice et al. Improving performance of mammalian cells in fed‐batch processes through “bioreactor evolution”
CN106987559A (zh) 一种重组chok1细胞株的构建方法及其应用
JP2021512618A (ja) 閉鎖系におけるcar−t細胞の製造方法
CN116716348A (zh) 一种提高重组细胞的蛋白表达量的方法
CN103320406A (zh) 高活力谷胱甘肽过氧化物酶gpx1突变体及其制备方法
CN112899238B (zh) 基于RNA-m6A修饰水平的化合物筛选细胞模型及其构建与应用
JPH04228066A (ja) 外来遺伝子発現用培養細胞
Suarez-Patino et al. Transient expression of rabies virus glycoprotein (RVGP) in Drosophila melanogaster Schneider 2 (S2) cells
KR102648479B1 (ko) 단백질 기반 의약들 (protein-based pharmaceuticals) 의 고 수준 생산을 위한 세포주들 (cell lines)
CN116004645B (zh) 一种利用昆虫细胞生产人血清白蛋白的方法、核苷酸序列及表达载体
JP2859679B2 (ja) 新規細胞株
US20060252152A1 (en) Attachment of cells to surfaces
JP2006141356A (ja) Es細胞から樹立された造血幹細胞
Despars et al. Heterogeneity amongst splenic stromal cell lines which support dendritic cell hematopoiesis
Knibbs et al. Sustained high‐yield production of recombinant proteins in transiently transfected COS‐7 cells grown on trimethylamine‐coated (hillex) microcarrier beads
Vatandoost et al. A study of recombinant factor IX in Drosophila insect S2 cell lines through transient gene expression technology
CN109517800A (zh) 一株补强胆固醇内源性合成的重构st细胞及其构建方法和用途